Enhanced Antibody Responses in CD19-Cre Mice

Overview

Journal Sci Rep

Date 2025 Jan 8

PMID 39779739

Authors

Diogo M Cunha

Sara Hernandez-Perez

Pieta K Mattila

Affiliations

Soon will be listed here.

Abstract

CD19-Cre is an important and widely used Cre-lox model for B cell-specific genetic manipulation in murine systems. Mice carrying one allele of CD19-Cre are, at the same time, rendered heterozygote for CD19, a crucial coreceptor of the B cell antigen receptor (BCR). As a result, CD19-Cre mice exhibit diminished expression levels of CD19, with potential, yet insufficiently examined, consequences in B cell activation. Here, we report significantly heightened antibody responses upon both T-dependent (NP-KLH) and T-independent (NP-Ficoll) immunizations as well as elevated levels of basal IgM immunoglobulin levels in CD19-Cre mice. In vitro, we observed enhanced class-switch recombination and a moderate reduction in B cell proliferation upon LPS and IFNγ stimulation, yet no drastic differences in BCR signalling. Our findings warrant careful consideration in the use of CD19-Cre mouse model in B cell research.

References

Hussain R, Cravens P, Miller-Little W, Doelger R, Granados V, Herndon E . α4-integrin deficiency in B cells does not affect disease in a T-cell-mediated EAE disease model. Neurol Neuroimmunol Neuroinflamm. 2019; 6(4):e563. PMC: 6481229. DOI: 10.1212/NXI.0000000000000563. View

Kraus M, Alimzhanov M, Rajewsky N, Rajewsky K . Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell. 2004; 117(6):787-800. DOI: 10.1016/j.cell.2004.05.014. View

Fearon D, Carroll M . Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol. 2000; 18:393-422. DOI: 10.1146/annurev.immunol.18.1.393. View

Victoratos P, Lagnel J, Tzima S, Alimzhanov M, Rajewsky K, Pasparakis M . FDC-specific functions of p55TNFR and IKK2 in the development of FDC networks and of antibody responses. Immunity. 2006; 24(1):65-77. DOI: 10.1016/j.immuni.2005.11.013. View

Rickert R, Rajewsky K, Roes J . Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature. 1995; 376(6538):352-5. DOI: 10.1038/376352a0. View

Wang Y, Brooks S, Li X, Anzelon A, Rickert R, Carter R . The physiologic role of CD19 cytoplasmic tyrosines. Immunity. 2002; 17(4):501-14. DOI: 10.1016/s1074-7613(02)00426-0. View

Rickert R, Roes J, Rajewsky K . B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 1997; 25(6):1317-8. PMC: 146582. DOI: 10.1093/nar/25.6.1317. View

Mattila P, Feest C, Depoil D, Treanor B, Montaner B, Otipoby K . The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling. Immunity. 2013; 38(3):461-74. DOI: 10.1016/j.immuni.2012.11.019. View

Engel P, Zhou L, Ord D, Sato S, Koller B, Tedder T . Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 1995; 3(1):39-50. DOI: 10.1016/1074-7613(95)90157-4. View

10.

van Zelm M, Reisli I, van der Burg M, Castano D, van Noesel C, Van Tol M . An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med. 2006; 354(18):1901-12. DOI: 10.1056/NEJMoa051568. View

11.

Tedder T . CD19: a promising B cell target for rheumatoid arthritis. Nat Rev Rheumatol. 2009; 5(10):572-7. DOI: 10.1038/nrrheum.2009.184. View

12.

Depoil D, Fleire S, Treanor B, Weber M, Harwood N, Marchbank K . CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol. 2007; 9(1):63-72. DOI: 10.1038/ni1547. View

13.

Fujimoto M, Sato S . B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity. J Dermatol Sci. 2007; 46(1):1-9. DOI: 10.1016/j.jdermsci.2006.12.004. View

14.

Pasqualucci L, Klein U . Mouse Models in the Study of Mature B-Cell Malignancies. Cold Spring Harb Perspect Med. 2020; 11(4). PMC: 8015697. DOI: 10.1101/cshperspect.a034827. View

15.

Mattila P, Batista F, Treanor B . Dynamics of the actin cytoskeleton mediates receptor cross talk: An emerging concept in tuning receptor signaling. J Cell Biol. 2016; 212(3):267-80. PMC: 4748574. DOI: 10.1083/jcb.201504137. View

16.

Yasuda T, Saito Y, Ono C, Kawata K, Baba A, Baba Y . Generation and characterization of CD19-iCre mice as a tool for efficient and specific conditional gene targeting in B cells. Sci Rep. 2021; 11(1):5524. PMC: 7943778. DOI: 10.1038/s41598-021-84786-6. View

17.

Sarapulov A, Petrov P, Hernandez-Perez S, Sustar V, Kuokkanen E, Cords L . Missing-in-Metastasis/Metastasis Suppressor 1 Regulates B Cell Receptor Signaling, B Cell Metabolic Potential, and T Cell-Independent Immune Responses. Front Immunol. 2020; 11:599. PMC: 7176992. DOI: 10.3389/fimmu.2020.00599. View

18.

Zhao Y, Zhao S, Qin X, He T, Hu M, Gong Z . Altered Phenotype and Enhanced Antibody-Producing Ability of Peripheral B Cells in Mice with -Driven Cre Expression. Cells. 2022; 11(4). PMC: 8870415. DOI: 10.3390/cells11040700. View

19.

Sato S, Miller A, HOWARD M, Tedder T . Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J Immunol. 1997; 159(7):3278-87. View

20.

Srinivas S, Watanabe T, Lin C, WILLIAM C, Tanabe Y, Jessell T . Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol. 2001; 1:4. PMC: 31338. DOI: 10.1186/1471-213x-1-4. View